Fibrolndex, a practical index for predicting significant fibrosis in patients with chronic hepatitis C

Hepatology

Volumn 45, Issue 2, 2007, Pages 297-306

  Koda, Masahiko ^a   Matunaga, Yoshiko ^a   Kawakami, Manri ^a   Kishimoto, Yukihiro ^b   Suou, Takeaki ^a   Murawaki, Yoshikazu ^a  

^a TOTTORI UNIVERSITY   (Japan)

^b SAN IN ROSAI HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOTRANSFERASE; IMMUNOGLOBULIN; RECOMBINANT INTERFERON; GLUTAMYL AMINOPEPTIDASE;

ADULT; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; DISEASE MARKER; FEMALE; FIBROINDEX; HEPATITIS C; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; LABORATORY TEST; LIVER BIOPSY; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; PROTEIN ANALYSIS; RATING SCALE; ROC CURVE; SENSITIVITY AND SPECIFICITY; STATISTICAL ANALYSIS; THROMBOCYTE COUNT; VALIDATION STUDY; VALIDITY; BIOLOGICAL MODEL; BLOOD; CROSS-SECTIONAL STUDY; DISEASE COURSE; ENZYMOLOGY; HOSPITALIZATION; LIVER CIRRHOSIS; LONGITUDINAL STUDY; METABOLISM; MIDDLE AGED; PATHOLOGY; PREDICTION AND FORECASTING; THROMBOCYTE;

ADULT; BLOOD PLATELETS; CROSS-SECTIONAL STUDIES; DISEASE PROGRESSION; FEMALE; GAMMA-GLOBULINS; GLUTAMYL AMINOPEPTIDASE; HEPATITIS C, CHRONIC; HUMANS; LIVER CIRRHOSIS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; PREDICTIVE VALUE OF TESTS; SEVERITY OF ILLNESS INDEX;

EID: 33847705375     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.21520     Document Type: Article

References (30)

1. Perrault J, McGill DB, Ott BJ, Taylor WF. Liver biopsy: complications in 1000 inpatients and outpatients. Gastroenterology 1978;74:103-106.
2. Wong JB, Koff RS for the International Hepatitis Interventional Therapy Group. Watchful waiting with periodic liver biopsy versus immediate empirical therapy for histologically mild chronic hepatitis C. Ann Intern Med 2000;133:665-675.
3. The French METAVIR Cooperative Study Group. Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. HEPATOLOGY 1994;20:15-20.
4. Rousselet MC, Michalak S, Dupré F, Croué A, Bedossa P, Saint-André JP, et al.; Hepatitis Network 49. Sources of variability in histological scoring of chronic viral hepatitis. HEPATOLOGY 2005;41:257-264.
5. Poynard T, Bedossa P, METAVIR and CLINIVIR cooperative study groups. Age and platelet count: a simple index for predicting the presence of histological lesions in patients with antibodies to hepatitis C virus. J Viral Hepat 1997;4:199-208.
6. Ono E, Shiratori Y, Okudaira T, Imamura M, Teratani T, Kanai F, Kato N, et al. Platelet count reflects stage of chronic hepatitis C. Hepatol Res 1999;15:192-200.
7. Imbert-Bismut F, Ratziu V, Pieroni L, Charlotte F, Benhamou Y, Poynard T; MULTIVIRC Group. Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study. Lancet 2001;357:1069-1075.
8. Forns X, Ampurdanès S, Llovet JM, Aponte J, Quintó L, Martínez-Bauer E, et al. Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model. HEPATOLOGY 2002;36:986-992.
9. Wai CT, Greenson JK, Fontana RJ, Kalbfleisch JD, Marrero JA, Conjeevaram HS, et al. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. HEPATOLOGY 2003;38:518-526.
10. Murawaki Y, Ikuta Y, Okamoto K, Koda M, Kawasaki H. Diagnostic value of serum markers of connective tissue turnover for predicting histological staging and grading in patients with chronic hepatitis C. J Gastroenterol 2001;36:399-406.
11. Rosenberg WM, Voelker M, Thiel R, Becka M, Burt A, Schuppan D, et al. Serum markers detect the presence of liver fibrosis: a cohort study. Gastroenterology 2004;127:1704-1713.
12. Colli A, Fraquelli M, Andreoletti M, Marino B, Zuccoli E, Conte D. Severe liver fibrosis or cirrhosis: accuracy of US for detection - analysis of 300 cases. Radiology 2003;227:89-94.
13. Hirata M, Akbar SM, Horiike N, Onji M. Noninvasive diagnosis of the degree of hepatic fibrosis using ultrasonography in patients with chronic liver disease due to hepatitis C virus. Eur J Clin Invest 2001;31:528-535.
14. Castéra L, Vergniol J, Foucher J, Le Bail B, Chanteloup E, Haaser M, et al. Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C. Gastroenterology 2005;128:343-350.
15. Ziol M, Handra-Luca A, Kettaneh A, Christidis C, Mal F, Kazemi F, et al. Noninvasive assessment of livet fibrosis by measurement of stiffness in patients with chronic hepatitis C. HEPATOLOGY 2005;41:48-54.
16. Bedossa P, Poynard T for The METAVIR Cooperative Study Group. An algorithm for the grading of activity in chronic hepatitis C. HEPATOLOGY 1996;24:289-293.
17. Attallah AM, Shiha GE, Omran MM, Zalata KR. A discriminant score based on four routine laboratory blood tests for accurate diagnosis of severe fibrosis and/or liver cirrhosis in Egyptian patients with chronic hepatitis C. Hepatol Res 2006;34:163-169.
18. Sakumoto I, Kikuchi N, Takane T, Yoshida H, Hosaka H. Studies on the relationship between the histological changes and liver cell function or plasma proteins in hepatic diseases. Gastroenterol Jpn 1976;11:224-236.
19. Ikeda K, Saitoh S, Kobayashi M, Suzuki Y, Tsubota A, Suzuki F, et al. Distinction between chronic hepatitis and liver cirrhosis in patients with hepatitis C virus infection. Practical discriminant function using common laboratory data. Hepatol Res 2000;18:252-266.
20. Alberti A. Towards more individualized management of hepatitis C virus patients with initially or persistently normal alanineaminotransferase levels. J Hepatol 2005;42:266-274.
21. Murawaki Y, Ikuta Y, Koda M, Nishimura Y, Kawasaki H. Clinical significance of serum hyaluronan in patients with chronic viral liver disease. J Gastroenterol Hepatol 1996;11:459-65.
22. Murawaki Y, Ikuta Y, Koda M, Kawasaki H. Serum type III procollagen peptide, type IV collagen 7S domain, central triple-helix of type IV collagen and tissue inhibitor of metalloproteinases in patients with chronic viral liver disease: relationship to liver histology. HEPATOLOGY 1994;20:780787.
23. Murawaki Y, Ikuta Y, Nishimura Y, Koda M, Kawasaki H. Serum markers for connecrive tissue turnover in patients with chronic hepatitis B and chronic hepatitis C: a comparative analysis. J Hepatol 1995;23:145-152.
24. Gabrielli GB, Capra F, Casaril M, Squarzoni S, Tognella P, Dagradi R, et al. Serum laminin and type III procollagen in chronic hepatitis C. Diagnostic value in the assessment of disease activity and fibrosis. Clin Chim Actal 1997;265:21-31.
25. Idobe Y, Murawaki Y, Ikuta Y, Koda M, Kawasaki H. Post-prandial serum hyaluronan concentration in patients with chronic liver disease. Intern Med 1998;37:568-575.
26. Murawaki Y, Idobe Y, Ikuta Y, Koda M, Yamamoto H, Maruyama S, et al. Influence of a history of gastrectomy for gastriccancer on serum hyaiuronan concentration in normal individuals and patients with chronic liver disease. Hepatol Res 1998;10:248-254.
27. Calès P, Oberti F, Michalak S, Hubert-Fouchard I, Rousselet MC, Konaté A, et al. A novel panel of blood markers to assess the degree of liver fibrosis. HEPATOLOGY 2005;42:1373-1381.
28. Patel K, Gordon SC, Jacobson I, Hézode C, Oh E, Smith KM, et al. Evaluation of a panel of non-invasive serum markers to differentiate mild from moderate-to-advanced liver fibrosis in chronic hepatitis C patients. J Hepatol 2004;41:935-942.
29. Poynard T, Imbert-Bismut F, Ratziu V, Chevret S, Jardel C, Moussalli J, et al. Biochemical markers of liver fibrosis in patients infected by hepatitis C virus: longitudinal validation in a randomized trial. J Viral Hepat 2002;9:128-133.
30. Poynard T, McHutchison J, Manns M, Myers RP, Albrecht J. Biochemical surrogate markers of liver fibrosis and activity in a randomized trial of peginterferon alfa-2b and ribavirin. HEPATOLOGY 2003;38:481492.